Share this post on:

Uring dreams were the best explanatory variables, accounting for 50 of variance. However, caution is required in interpretation of these results, because two out of these three variables (i.e. UPDRS III and Sexual disturbances) have been used to generate the clusters. Nevertheless, these results might suggest that two main axes (motor and non-motor) should be used to clinically classify PD patients, playing such demographic features as age and gender a minor role. We acknowledge that our study has some limitations. First, our cohort is unlikely to be representative of the whole parkinsonian population due to the recruitment performed in a tertiary care. Presumably, as patients referring to the tertiary care are usually younger [46], this type of recruitment is responsible for the lower age at onset as compared to naturalistic, community-based cohorts [47]. It may be also argued that with such follow-up (i.e. 2 years after the enrollment) some of our patients may have an atypical parkinsonism masquerading PD. We obviously can not definitively rule out the chance that someone can still convert into a diagnosis other than PD over the long-term period, but this would be unlikely. Indeed, mean disease duration of our cohort at the last examination was 36.867.6 months. This means that we are dealing with a three-year span, during which it would be very unlikely for an atypical syndrome to mimic a pure PD without any atypical sign. It would furthermore involve a very small percentage of patients (5 of patients had been already excluded for thisThe Heterogeneity of Early Parkinson’s Diseasereason as stated in the Results section) to interfere with the statistical power and overall interpretation. Another exclusion criteria of ours, was treatment with antidepressant or anxiolytic drugs, and this might have lead to underestimation of depression and anxiety in our cohort. However, this issue should have played a minor role. Indeed, prevalence of depression and anxiety in our cohort was 45 and 54 , respectively, in line with previous reports [33]. Finally, our neuropsychological data were limited, thus hampering comparisons with previous studies focused on cognition in PD. It has been indeed unveiled that there is heterogeneity also when looking at cognitive performances in an incident PD cohort, being posterior cognitive deficits the strongest predictor for future development of dementia [48,49]. In conclusion, the identification of these subgroups ought to serve more as a model for testing hypotheses, rather than as adefinitive classification system, which should require final clinicalpathological data correlation. The existence of these subgroups needs of course IQ-1 supplier further validation on independent cohorts of patients. Because our research project is ongoing and further publications are in preparation, data cannot yet be made widely accessible. However, we would be pleased to collaborate with other teams in the field. Researchers are encouraged to contact either the first author ([email protected]) or the corresponding author ([email protected]) with suggestions for collaboration or data sharing.Author ContributionsConceived and designed the experiments: RE CV PB. Performed the experiments: RE CV MA MP KL GS MM RA FG GDM ADR LS GO MTP. Analyzed the data: RE CV. Wrote the paper: RE CV PB.
Lung cancer continues to be a major public health problem in both men and women, it is currently the cancer type with the highest MedChemExpress 520-26-3 mortality worldwide. The in.Uring dreams were the best explanatory variables, accounting for 50 of variance. However, caution is required in interpretation of these results, because two out of these three variables (i.e. UPDRS III and Sexual disturbances) have been used to generate the clusters. Nevertheless, these results might suggest that two main axes (motor and non-motor) should be used to clinically classify PD patients, playing such demographic features as age and gender a minor role. We acknowledge that our study has some limitations. First, our cohort is unlikely to be representative of the whole parkinsonian population due to the recruitment performed in a tertiary care. Presumably, as patients referring to the tertiary care are usually younger [46], this type of recruitment is responsible for the lower age at onset as compared to naturalistic, community-based cohorts [47]. It may be also argued that with such follow-up (i.e. 2 years after the enrollment) some of our patients may have an atypical parkinsonism masquerading PD. We obviously can not definitively rule out the chance that someone can still convert into a diagnosis other than PD over the long-term period, but this would be unlikely. Indeed, mean disease duration of our cohort at the last examination was 36.867.6 months. This means that we are dealing with a three-year span, during which it would be very unlikely for an atypical syndrome to mimic a pure PD without any atypical sign. It would furthermore involve a very small percentage of patients (5 of patients had been already excluded for thisThe Heterogeneity of Early Parkinson’s Diseasereason as stated in the Results section) to interfere with the statistical power and overall interpretation. Another exclusion criteria of ours, was treatment with antidepressant or anxiolytic drugs, and this might have lead to underestimation of depression and anxiety in our cohort. However, this issue should have played a minor role. Indeed, prevalence of depression and anxiety in our cohort was 45 and 54 , respectively, in line with previous reports [33]. Finally, our neuropsychological data were limited, thus hampering comparisons with previous studies focused on cognition in PD. It has been indeed unveiled that there is heterogeneity also when looking at cognitive performances in an incident PD cohort, being posterior cognitive deficits the strongest predictor for future development of dementia [48,49]. In conclusion, the identification of these subgroups ought to serve more as a model for testing hypotheses, rather than as adefinitive classification system, which should require final clinicalpathological data correlation. The existence of these subgroups needs of course further validation on independent cohorts of patients. Because our research project is ongoing and further publications are in preparation, data cannot yet be made widely accessible. However, we would be pleased to collaborate with other teams in the field. Researchers are encouraged to contact either the first author ([email protected]) or the corresponding author ([email protected]) with suggestions for collaboration or data sharing.Author ContributionsConceived and designed the experiments: RE CV PB. Performed the experiments: RE CV MA MP KL GS MM RA FG GDM ADR LS GO MTP. Analyzed the data: RE CV. Wrote the paper: RE CV PB.
Lung cancer continues to be a major public health problem in both men and women, it is currently the cancer type with the highest mortality worldwide. The in.

Share this post on:

Author: haoyuan2014